Decode Reports Decreased Q3 Revenues

Nov 14, 2002

NEW YORK, Nov. 14 - Decode Genetics today reported decreased revenue for the third quarter of 2002.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Already have an account?
Login Now.

Breaking News

Researchers Use CRISPR to Explore Genes Relevant to Human Embryonic Development
Expanded Human Microbiome Project Examines Dynamics, Functions of Microbial Communities
MBS Inks Multiple Distribution Agreements for PCR Platform
Natera, Aarhus University to Collaborate on Liquid Biopsy Study for Bladder Cancer
Paternal, Maternal Aging Linked to Distinct De Novo Mutation Jumps in Children
Hearst Invests $75M in M2Gen

The Scan

Synthetic Genomics Sued for Gender Discrimination

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Football Team's DNA Day Postponed

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

To Interfere

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

This Week in Cell

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.

Main menu